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Eosinophils are multifunctional granulocytes that play an imperative role in health and disease. They have also been found to be a crucial 
component of peri- and intratumoral inflammatory infiltrate. Tumor-associated tissue eosinophilia (TATE) has been observed and de-
scribed in many tumors, including head and neck neoplasia. The process of eosinophil recruitment and its function in tumors has not been 
exactly defined yet. Correlation of tissue eosinophilia with prognosis has shown variable results ranging from favourable to unfavourable 
prognosis or even having no influence on patients outcome. Eosinophils are hypothesized to have tumor defensive as well as tumor promo-
tive function. This dichotomous role of tissue eosinophilia with regard to prognosis has also been noted in head and neck neoplasia and 
premalignancies. So, the present review attempts to discuss TATE and its possible pros and cons in head and neck neoplasia.
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INTRODUCTION
Eosinophils are bone marrow derived multifunctional 
granulocytes implicated in pathogenesis of allergic 
reactions and parasitic infections [1, 2]. Tumor-asso-
ciated tissue eosinophilia (TATE) was first described 
by Prezewoski in 1896 as “eosinophilic stromal infil-
tration of a tumor not associated with tumor necrosis 
or ulceration” [3]. TATE is characterized by presence 
of eosinophils as a component of peri- and intratumoral 
inflammatory infiltrate [4]. Literature search showed that 
TATE has been associated with malignancies of diffe-
rent sites such as oral cavity [4–12], nasopharynx [13], 
la rynx [14, 15], esophagus [16], colon [17], cervix [18, 
19], etc. Correlation of TATE with prognosis in malignan-
cies of different sites including head and neck squa-
mous cell carcinoma (HNSCC) have shown variable 
results ranging from favourable [4, 6, 13, 16] to unfa-
vourable [12, 19] prognosis or even having no influence 
on patients outcome [3, 9]. Thus, the link between TATE 
and patients outcome is not exactly evident. Dualistic 
role of eosinophils might be attributed to the fact that 
eosinophils have direct and indirect tumoricidal activity 
as well as, they may promote tumor angiogenesis via 
production of se veral angiogenic factors [20]. The pre-
sent review aims to discuss TATE and evaluate possible 
correlation between TATE and various clinicopathologi-
cal para meters in head and neck squamous neoplasia 
through the data derived from available literature.
Detection of eosinophils in cancer
Eosinophils can be easily identified in tissue sections 
stained with hematoxylin and eosin (Fig. 1) but at times, 
these granulocytes assume an unusual morphology 
making their identification difficult particularly in fibrous 
tissue or inflammatory infiltrate. Such conditions entail 
the usage of special technique like autofluorescence, 
immunohistochemistry, luna staining and special stains 
like Congo red (Fig. 2) and carbol chromotrope for re-
velation of intact or degranulating eosinophils [21–24].
Fig. 1. Eosinophils in oral squamous cell carcinoma (OSCC) 
stained by hematoxylin — eosin, × 40
Fig. 2. Eosinophils in OSCC stained by Congo red, × 40
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Criteria for identification of eosinophils
Literature reviewed suggested that only nucleated 
cells with intensely red cytoplasmic granules should 
be accepted as eosinophils. Care must be taken to ex-
clude red blood cells with superimposed mononuclear 
and polymorphonuclear cells and also those confined 
to lymphovascular space must be disregarded [9, 15]. 
In addition, an effort should be made to discount eosino-
philia associated with tumor necrosis or ulceration [3, 13].
Counting of tumor-associated tissue eosinophils
There are basically 2 methods described for eosi-
nophil counting. In classical counting, eosinophils are 
counted per high power field (hpf) in sections of tumor 
or tumor edge or surrounding stroma randomly. In den-
sity method, the highest eosinophil density per surface 
area are counted using grid of definite dimensions [4, 
25]. However, Alkhabuli and High [25] concluded that 
assessment of density may be better than classical 
counting and have more relationship with function.
Degree of TATE
Degree of TATE can be evaluated depending upon 
either counts only (number of eosinophils/mm2 or hpf) 
as absent/mild, moderate, intense 4 or on the basis 
of both counts and distribution as focally and mo-
derately elevated, focally and markedly increased, 
diffusely and moderately elevated, diffusely and 
 markedly increased [15]. However, grading of TATE has 
got subjective variations since there is no consensus 
about the classification of TATE and different grading 
scales being used by various investigators [6, 8, 26].
Tissue eosinophils and HNSCC
TATE and clinical correlations in HNSCC
TATE and age and sex. Most of studies found that 
there is no correlation of TATE with age [4, 11] and 
sex [4, 5, 11, 13, 27] but, Ercan et al. [28] concluded 
that there is a negative correlation between TATE and 
age (in laryngeal squamous cell cancer) with lesser inci-
dence of TATE over age of 60 years suggesting that age 
influences the tissue inflammatory response to tumor.
TATE and habits. Dorta et al. [4] and Oliveira 
et al. [5] did not found any association between TATE 
and tobacco and alcohol consumption in OSCC but 
Oliveira et al. [11] found that intense TATE is sig-
nificantly associated with alcohol consumption only 
or with a long history of combined alcohol intake and 
cigarette smoking in OSCC.
TATE and tumor site. Dorta et al. [4] assessed TATE 
in OSCC of tongue, floor of the mouth, retromolar area 
and inferior gingiva and Oliveira et al. [11] analyzed 
TATE in OSCC of tongue and floor of the mouth but they 
did not found any statistically significant differences 
in the distribution of eosinophils among these sites.
TATE and TNM staging. Oliveira et al. [5] found that 
patients with OSCC in early stages T1/T2 presented 
absent/mild TATE, whereas intense tissue eosinophilia 
was strongly associated with tumors in advanced sta-
ges T3/T4. Dorta et al. [4] revealed that TATE is an in-
dependent prognostic factor and does not correlates 
with T and N clinical stage. Also, Oliveira et al. [11] and 
Thompson et al. [14] noticed statistically insignificant 
association between TATE status and tumor T category 
of patients with OSCC and SCC of larynx, respectively.
TATE and pathological correlations in HNSCC
TATE and stromal invasion. Said et al. [15] found 
frequently elevated (focally or diffusely) eosinophilic 
counts in invasive squamous neoplasia of larynx com-
pared to preinvasive squamous neoplasia. Furthermore, 
increased eosinophil counts, specifically > 10/hpf and 
> 20/10 hpf were statistically significantly associated 
with stromal invasion. Thus, in an excisional specimen, 
if eosinophil counts meet these threshold, thorough 
evaluation of invasiveness is mandatory. Similar  findings 
were reported by Alrawi et al. [8] in patients with in situ 
and invasive HNSCC. Our study [29] also found raised 
eosinophil counts in OSCC compared to oral epithe-
lial dysplasia thus concluding that elevated eosi nophil 
count is a histopathological marker associated with 
tumor invasion. Falconieri et al. [30] also concluded 
that eosinophil-rich SCC is constantly associated with 
stromal invasion and is of noteworthy especially in oral 
cavity cases where it becomes difficult to estimate 
due to initial small biopsy specimens. In such cases, 
marked tissue eosinophilia is suggestive of an SCC that 
is no longer confined within mucosal surface.
TATE and histological tumor type and tumor diffe-
rentiation. Lowe and Fletcher [26] suggested that TATE 
development in skin and mucous membrane is in some 
way related to squamous differentiation of tumor since 
it is rarely reported in basal cell carcinomas and malig-
nant melanoma. Also, it was proved that TATE is neither 
a site specific reaction nor a general disposition of pa-
tient to exhibit eosinophilia around any tumor. Moreover, 
they found that all of the tumors showing massive TATE 
were large cell poorly keratinizing, moderately differenti-
ated and none was verrucous type SCC which possibly 
reflects that a particular pattern of squamous differen-
tiation or dedifferentiation is linked in some way with 
tissue eosinophil response. Rahrotaban et al. [24] found 
that TATE was lower in poorly differentiated HNSCC but 
correlation between TATE and histopathological grading 
(Broders system) was not statistically significant. Also, 
Tadbir et al. [9] and Ercan et al. [28] did not found any 
significant relation between TATE and tumor differen-
tiation in OSCC and laryngeal SCC, respectively. Looi 
et al. [13] observed TATE more frequently in non kera-
tinizing nasopharyngeal carcinoma (NPC) compared 
to keratinizing SCCs and undifferentiated carcinomas.
TATE and its precise localization. Dorta et al. [4] 
found that eosinophil infiltrate location was statistically 
associated with TATE. In case of absent/mild/mode-
rate TATE, eosinophils were exclusively limited to tumor 
stroma whereas in cases with intense TATE, eosinophils 
showed accumulation both in neoplastic clusters and 
tumor stroma. Another study [9] found mean eosinophil 
count/10 hpfs to be higher in invasive front of tumor than 
intratumoral stroma and stroma subjacent to epithelium 
but the correlation was not significant.
TATE and peripheral tissue infiltration/invasion. 
Few studies [5, 9, 11, 28] evaluated association 
of TATE with perineural, vascular, muscular glandular 
Experimental Oncology 36, 157–161, 2014 (September) 159
and bone invasion but none of them found any sig-
nificant correlation. Oliveira [5] observed eosinophilia 
in close association with damaged striated muscle 
fibers. Also, majority of OSCC with absent muscular 
infiltration showed absent/mild eosinophilia, although 
the correlation was statistically insignificant. So, they 
hypothesize that eosinophils might be involved in tis-
sue remodeling through the release of their granules 
causing degradation of muscle fibers which are da-
maged by invasion of malignant cells.
Association of eosinophils with mast cells and in-
flammatory response. Debta et al. [10, 22] observed 
increased number of tissue eosinophils in OSCC cases 
accompanied by increase infiltration of mast cells. 
Increase infiltration of these cells were associated with 
improved prognosis indicative of antitumoral activity.
Dorta et al. [4] found statistically significant relation 
between mononuclear inflammatory infiltrate intensity 
and TATE in OSCC. This might involve a multifarious and 
cumulative interplay of many molecules including release 
of lymphocyte derived eosinophilotactic cytokines [4, 
31]. Sassler et al. [27] observed an increased prevalence 
of TATE in those laryngeal SCC which de mon strated high 
degree of inflammatory response which might be at-
tributed to tumor derived peptides causing chemotaxis 
of these cellular elements. Likewise, Lorena et al. [23] 
found intimate association of eosinophils with strong 
lymphoplasmacytic cell infiltration in OSCC. Looi [13] also 
noticed that eosinophils were present mainly between 
groups of neoplastic cells admixed with lymphocytes 
and plasma cells in NPC. On the contrary, Goldsmith 
et al. [6] did not found any correlation between grades 
of inflammation and eosinophilia in OSCC. Findings 
by Said et al. [15] also depicted that there is no associa-
tion of elevated tissue eosinophils with overall inflamma-
tory response denoting that ele vated tissue eosinophilia 
is a specific cell response independent of a non-specific 
inflammatory reaction.
TATE and second primary tumor (SPTs)
Very few studies [5, 11] correlated TATE with SPTs 
but no statistically significant association was found.
TATE as a prognosticator in HNSCC
TATE and recurrence. Oliveira et al. [5] and Leighton 
et al. [3] concluded that TATE is not a significant predic-
tor of locoregional and local recurrence in OSCC and 
NPC, respectively, where as Oliveira et al. [11] in OSCC 
noticed that TATE was highly correlated with regional 
recurrence but not with local recurrence. Study by Alrawi 
et al. [8] on HNSCC revealed potential association be-
tween higher eosinophilic index (EI >2) and locoregional 
recurrence suggesting that elevated eosinophilic counts 
is a predictor for aggressive tumor biology demanding 
close surveillance and additional therapeutic measures.
TATE and metastasis. Our study [29] found signifi-
cantly increased eosinophil counts in non-metastatic 
OSCC compared to metastatic OSCC justifying TATE 
as a favourable prognosticator. Falconieri et al. [30] 
found heavy eosinophilia in all metastatic lymph nodes 
of eosinophil-rich OSCC indicating that tumoral rather 
than local factors are involved in eosinophilic migration. 
Moreover, eosinophili-rich SCC associated with meta-
static involvement followed less violent course in con-
trast to ordinary SCC. Oliveira et al. [11] suggested that 
TATE is a significant marker to predict occult lymph node 
metastasis in patients with early OSCC and also an ad-
junctive histopathological factor to emphasize the call 
for elective neck dissection of patients with clinically 
N0 early OSCC. Goldsmith et al. [32] found that high 
grade TATE was statistically associated with absence 
of distant metastasis but the underlying pathogenetic 
mechanism remains unknown. Looi [13] observed that 
in NPC, TATE in the primary tumor was not always as-
sociated with eosinophilia in the metastases. Leighton 
et al. [3] concluded that TATE is not a significant marker 
of distant metastasis in NPC. Tadbir et al. [9] and Ercan 
et al. [28] did not found any significant correlation be-
tween TATE and locoregional metastasis in OSCC and 
SCC of larynx, respectively.
TATE and treatment. Oliveira et al. [5, 11] did not noted 
any significant association between intensity of TATE 
and radiotherapy in OSCC. Sassler et al. [27] found that 
presence of TATE could not be used to predict response 
to induction chemotherapy.
TATE and survival. Dorta et al. [4] found that in OSCC, 
5 year disease free cumulative survival and overall cu-
mulative survival was better in patients with intense TATE 
(72% and 63%, respectively) compared to those with 
absent/mild (32% and 27%, respectively) and mode rate 
(44% and 37%, respectively) TATE. Thompson et al. [14] 
also demonstrated that over 5 years, TATE positive pa-
tients with laryngeal SCC have significantly improved 
survival compared with TATE negative patients. More-
over 1 year disease free survival (DFS) for TATE positive 
patients was 84% compared with 67% for TATE negative 
patients. Debta et al. [10] in OSCC cases found that 
patients who had survived for 3 years or more have 
raised tissue eosinophil counts in contrast to those who 
had survived for less than 3 years. So, above mentioned 
findings suggests that patients with higher numbers 
of tumor associated tissue eosinophils had a better 
prognosis than patients with intermediate or low counts. 
On the contrary, study by Alrawi et al. [8] in head and 
neck neoplasia cases demonstrated that patients with 
high EIs (3 and 4) had a statistically significant lower 
survival than those with lower EIs (1 and 2). In addi-
tion, patients with higher EIs had a significantly worse 
disease specific survival. However, Oliviera et al. [5, 
11] observed that there is no differences in the 5 year 
and 10 year overall survival and DFS rates between 
the OSCC patients with absent/mild and intense eosi-
nophilia and thus tissue eosinophilia is not a signifi-
cant risk factor for death in OSCC patients. Similarly, 
Leighton et al. [3] in NPC, Ercan et al. [28] and Sassler 
et al. [27] in laryngeal SCC concluded that TATE is not 
a significant predictor of survival. Hence, TATE has got 
variable prognostic role in head and neck neoplasia.
DISCUSSION
Cancer induced inflammatory response, further 
termed as “immune surveillance” by F.M. Burnet 
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involves host defensive response against tumors via 
array of infiltrating lymphoid and myeloid cells which 
might either promote or retard tumor progression [33, 
34]. Leucocyte infiltrate often fluctuate with type and 
size of tumor implying that immune responses are 
neither consistent nor static events [35, 36].
Eosinophils found to have dual and divergent func-
tion, i.e., tumor promotive as well as tumor destructive. 
Role of eosinophils in remodeling of connective tissue 
and formation of collagen was first proposed by Bassett 
in 1962 [21, 37]. Pincus et al. demonstrated that eosino-
phil can stimulate fibroblast DNA synthesis [38]. Eosino-
phils are found to express transforming growth factor 
β1 (TGF-β1) and also contain preformed MMP-9 and 
inhibitors of MMPs, TIMP-1 and 2 having potent effects 
on the extracellular matrix modulation [39, 40]. Eosino-
phils can amend the tissue remodeling process through 
the release of their distinct granule proteins. Eosinophil 
cationic protein inhibits proteoglycan degradation and 
promotes intracellular glycosaminoglycan accumulation 
in fibroblasts [41]. Major basic protein and eosinophil 
derived neurotoxin exhibit profibrogenic features stimu-
lating fibroblast proliferation [42]. Eosinophils infiltrating 
tumors also known to release angiogenesis promoting 
factors like transforming growth factor-α (TGF-α) [43], 
vascular endothelial growth factor (VEGF) and basic 
fibroblast growth factor (b-FGF) [44]. On the contrary, 
eosinophils can exhibit antitumor response via direct 
and/or indirect mechanism. In vitro studies have shown 
that eosinophils might cause direct cytotoxicity to tumors 
through release of their granules [45]. Indirectly, eosino-
phil peroxidase can act synergistically with macrophage 
reactive oxygen species and augment cytolysis of tumor 
cells [46] or catalyse the oxidation of nitrite to generate 
cytotoxic reactive nitrogen radicals [47].
Eosinophils can be related to cytokines of Th1 and 
Th2 response via synthesis and release of IFN-γ and 
IL-4, IL-5, and IL-10 [48, 49]. In HNSCC, it has been 
shown that the Th1 response is mainly associated 
with a better prognosis than those with the Th2 re-
sponse [50, 51]. Early stage of OSCC was found to ex-
press mainly INF-γ and IL-2 genes (Th1 responses) 
whereas the advanced stage tumors have IL-4 and 
IL-10 expression (Th2 response) [52].
Eosinophils have been recognized and reported as in-
flammatory cellular infiltrate of various human cancer 
particularly of epithelial origin including OSCC [4–19]. 
However, the precise role of eosinophils in tumor 
growth and patient survival is still doubtful. Eosinophil 
recruitment in these tumors might be allied to release 
of several factors which have been shown to be effective 
eosinophil attractant in in vitro and in vivo studies [21]. 
So, in nutshell, with regards to above data and available 
literature, although eosinophil recruitment in head and 
neck neoplasia has been supported by various facts and 
evidences but the functional role of eosinophils in human 
cancer remains obscure i.e, are eosinophils restraining 
tumor growth as a part of host surveillance mechanism 
or do they augment tumor growth by remodeling and 
immunoregulation of tumor microenvironment or even 
have no effect on tumor evolution? Studies related 
to prognostic value of TATE in HNSCC has emerged with 
conflicting results which demands further investigations 
elucidating precise function of eosinophils as a prognos-
ticator in head and neck neoplasia.
CONCLUSION
Present review is an effort to converse about dif-
ferent facet of TATE and its possible role and upshots 
in various head and neck squamous neoplasia. To our 
knowledge very little literature is available regarding 
same hence we hope that this review will contribute and 
add to present literature. Referred articles illustrated 
that TATE is an adjunctive microscopic feature that has 
momentous contribution to various clinico-histopa-
thological parameters in HNSCC including the patient 
outcome. So, it is recommended that quantitative as-
sessment of eosinophils should become part of the rou-
tine diagnosis. Exact mechanism of these cells whether 
they are involved in tumor inhibition or tumor promotion 
is still unknown and warrants further researches.
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